a:5:{s:8:"template";s:15011:"
{{ keyword }}
";s:4:"text";s:27833:"- free SYRS analysis to find out whether to buy or sell SYRS. That is because the Oct 15, 2021 $7.50 Call had some of the highest implied volatility of all equity options today. View real-time stock prices and stock quotes for a full financial overview. If you are looking for stocks with good return, Syros Pharmaceuticals Inc. stock can be a bad, high-risk 1-year investment option. Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price, News ... Net loss: US$26.0m (loss widened 34% from 3Q 2020). In May, ARK divested itself of 3.6 million of SYRS shares; however, the stock went up 18% on the same day, probably unrelated to ARK's sell-off of SYRS. News Syros Pharmaceuticals Inc.SYRS. A Stock You Ought To Watch Is Syros Pharmaceuticals Inc ... Penny Stocks (PennyStocks.com) is the top online destination for all things Micro-Cap Stocks. Feb-13-20 08:00AM. Syros Pharmaceuticals Inc Stock Forecast. Sep 20, 2021 8:38AM EDT. During the day the stock fluctuated 5.13% from a day low at $3.51 to a day high of $3.69. SYRS Stock | News | SYROS PHARMACEUTICALS Stock Price ... Syros Pharmaceuticals Stock Price Today (NASDAQ: SYRS ... Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 58.18% and 58.26%, respectively, for the quarter ended March 2021. Should You Buy SYRS Stock? Syros Pharmaceuticals Inc ( SYRS) is down -10.09%% today. Next reporting date: March 10, 2022 . Syros Pharmaceuticals Is A Buy As New Trials Start . Check out the latest ideas and forecasts on Syros Pharmaceuticals, Inc from our top authors — they share predictions and technical outlook of the market. Srys. Closing Price. Syros Prescribed drugs Inc. (SYRS) shares have gone down -61.53% over the last six months, with a year-to-date progress charge greater than the trade common at 18.23% in opposition to 8.80. 0 analysts . Syros Pharmaceuticals Inc (SYRS:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. The image below, which you can click on for greater detail, shows that at September 2021 Syros Pharmaceuticals had debt of US$40.1m, up from US$19.7m in one year. Date Event description Earnings per share actual Earnings estimate range Previous year's . Recent Posts. Jason Butler, analyst at JMP Securities, reiterates coverage on Syros Pharmaceuticals (SYRS) in the Healthcare sector with a Buy rating. report . Syros Pharmaceuticals ( SYRS ), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. Find real-time OMER - Omeros Corp stock quotes, company profile, news and forecasts from CNN Business. SYRS Stock Forecast - Is SYRS a buy or sell? SYRS: Get the latest Syros Pharmaceuticals stock price and detailed information including SYRS news, historical charts and realtime prices. By Cody Benson. Its SY-2101, a novel oral form of arsenic trioxide (ATO) being developed for the treatment of AML. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price . Should I buy or sell SYRS? By Sarah Baker November 24, 2021 At the end of the latest market close, Syros Pharmaceuticals Inc. (SYRS) was valued at $3.83. Find the latest Syros Pharmaceuticals, Inc. SYRS analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Heading into the fourth quarter of 2020, a total of 13 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of . Find out what this means to you and get the rest of the rankings on SYRS! Top 10 Penny Stocks +123.42%: Free Sigup: Penny Stocks: . The stock had a rough first half of 2021, but shares have significantly improved in the latter half of the year. The price target was changed from $4.42 to 6.8%. 52-Week Range 4.78 - 9.76. Dividend & Yield 0.10 (1.03%) Free Report. 11/5/2021 3/10/2022 5/12/2022 - - Revenue Estimates . Financials. View real-time stock prices and stock quotes for a full financial overview. SYRS, 1D. The following slide deck was published by Syros Pharmaceuticals, Inc. in conjunction with their 2021 Q2 earnings call. Syros Pharmaceuticals Inc. (SYRS): The stock long term indicators say Sell today. In the short term (2weeks), SYRS's stock price should underperform the market by -1.58%.During that period the price should oscillate between -11.69% and +12.29%. Heading into the second quarter of 2021, a total of 18 of the hedge funds tracked by Insider Monkey held long positions in this stock, a . Today's volume of 37,807 shares is on pace to be much lighter than SYRS's 10-day average volume of 305,410 shares. investment rating. SYRS Stock Summary Of note is the ratio of Syros Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 7.38% of US stocks have a lower such ratio. This chart shows the closing price for SYRS for the last year in relation to the current analyst high, average, and low pricetarget. Find out now with a free analysis on Syros Pharmaceuticals. 12/20/2021. The average price target represents a 418.73% upside from the last price of $3.47. As of December 31, 2020, we had an accumulated deficit of $377.0 million. ET on Friday, November 5, 2021 to report its third quarter 2021 financial results and provide a corporate update. Key Data. Syros Pharmaceuticals (NASDAQ:SYRS) is set to give its latest quarterly earnings report on Friday, 2021-11-05. Syros Pharmaceuticals (NASDAQ: SYRS) is $5.23 last updated Mon Sep 13 2021 20:00:02 GMT+0000 (Coordinated Universal Time). The company's lead product candidates are SY-1425, a . The inducement stock option award consists of an option to purchase a total of 750,000 shares of the Company's common stock with an exercise price of $4.54, equal to the closing price of the Company's common stock on October 12, 2021, the date of grant. The global learning management system market is poised to grow by $27.98 billion during 2021-2025, progressing at a CAGR of 20.19% during the forecast period. Syros Pharmaceuticals (NASDAQ:SYRS) is set to give its latest quarterly earnings report on Friday, 2021-11-05.Here's what investors need to know before the announcement. Syros Pharmaceuticals Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $3.55 -0.27 (-7.07%) Updated Dec 3, 2021 1W - 10.58% 1M - 19.13% 3M - 33.02% 1Y - 53.53% SYRS Price $3.55 Fair Value Price N/A Market Cap $282.48M 52 Week Low $3.51 52 Week High $15.65 P/E -2.18x P/B 2.66x P/S 13.15x PEG N/A Dividend Yield N/A Revenue Syros Pharmaceuticals ( SYRS ), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. Syros Pharmaceuticals has a 52-week low of $3.30 and a 52-week high of $15.49. The current price level -69.90% lower than the highest price of $15.65 marked by the stock while trading over the past . We expect our expenses to increase in connection with our planned . Over the last 3 years on average, earnings per share has increased by 8% per year but the company's . $4.04. Dive deeper with interactive charts and top stories of Liquid Media Group Ltd.. Syros Pharmaceuticals Stock Forecast NASDAQ: SYRS Price Target and Analyst Ratings Most Recent Rating On Sep 23, 2021 "Roth Capital" gave "$20.00 - $23.00" rating for SYRS. TipRanks.com has Cann rated as a 4.5 star analyst with a 14% return on investment and a 50% success rate.Cann has set a price target of $21.00 .. TipRanks.com reports that SYRS currently has 6 analysts offering 12-month price targets and the . Is Syros Pharmaceuticals Inc Stock Undervalued? Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Leah R Cann, analyst at Brookline Capital Markets, reiterates coverage on Syros Pharmaceuticals (SYRS) in the Healthcare sector with a Buy rating. They are provided . SYRS has an Overall Score of 48. and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.. Analysts estimate that . ©2021 Stock Scanner . Now . New powers for UK pension watchdog hit dealmaking; Lizhi signs in-car audio partnership with HiPhi; Turkey's Lira Slides Amid Questions Over Currency-Defense Tool; Amazon at $46. On PennyStocks.com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. Disclaimer: Stocksunder1.org does not endorse or suggest any of the securities which are returned in any of the searches or filters. The Syros Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null.The shares last closed at $3.50.. Oracle at $0.51. Third quarter 2021 results: Revenue: US$5.70m (up 49% from 3Q 2020). Free Signup: Advanced stock screener. Do Hedge Funds Think SYRS Is A Good Stock To Buy Now? 2021 is expected to be a huge year for penny stocks. Find real-time SYRS - Syros Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. . ET on Friday, November 5, 2021 to report its third quarter 2021 financial results and provide a corporate update. 37,807 December 16, 2021 11:08am ET . SYRS stock closed at $5.45 and is down -$0.55 during pre-market trading. ©2021 Stocks Under $1. . November 24, 2021 No Comments At the end of the latest market close, Syros Pharmaceuticals Inc. (SYRS) was valued at $3.83. SYRS Stock Predictions, Articles, and Syros Pharmaceuticals News From the Web 12 Health Care Stocks Moving In Friday's Pre-Market Session From Benzinga Dec 3, 2021 Gainers Celyad Oncology. No news for in the past two years. The stock price for . Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Learning Management System Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Analyst recommendations provided by FactSet shows that the consensus forecast for Syros Pharmaceuticals Inc. (SYRS) is a "Buy". Stock Predictons by days: 2021 Search Stock, FX pair, Crypto, or Commodity. The consensus EPS Estimate is -$0.44 (-2.3% Y/Y) and the consensus Revenue Estimate. Revenue growth over the past 12 months for Syros Pharmaceuticals Inc comes in at 115.95%, a number that bests 93.85% of the US stocks we're tracking. Syros Pharmaceuticals NASDAQ Updated Dec 23, 2021 9:00 PM. The average price target is $18.00, with a high forecast of $23.00 and a low forecast of $14.00. Aqaryouti. The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Its SY-5609, is a selective and potent oral inhibitor of cyclin-dependent kinase 7 (CDK7) that is being evaluated in the dose escalation portion in patients with select advanced solid tumors. SYRS | Complete Syros Pharmaceuticals Inc. stock news by MarketWatch. SYRS Stock Predictions - will SYRS go up or down? . 8 analysts offering their recommendations for the stock have an average rating of 1.90, where 0 rate it as a Hold and 0 think it is a "Overweight". In that particular session, Stock kicked-off at the price CAMBRIDGE, Mass., October 29, 2021--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. Day's Range 9.38 - 9.53. SYRS is currently trading in the 60-70% percentile range relative to its historical . Forecast for Fri 18 Feb 2022 price 5.22 . X. . The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Yet analysts are ramping up their growth forecast for the fiscal year 2021. TipRanks.com has Butler rated as a 3.5 star analyst with a 6% return on investment and a 44% success rate.Butler has set a price target of $20.00 .. TipRanks.com reports that SYRS currently has 5 analysts offering 12-month price targets and the consensus is a . He found Apple at $1.49. Shareholders in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts.The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals. 52wk Low 3.30. More on SYRS. SYRS 3.64 0.17 (4.90%) Post-Market 0.00 (0.00%) 1,636. Syros Pharmaceuticals Inc. (SYRS) shares have gone down -30.98% during the last six months, with a year-to-date growth rate more than the industry average at 17.68% against 7.30. SYRS stock forecast Our latest prediction for Syros Pharmaceuticals Inc.'s stock price was made on the July 17, 2019 when the stock price was at 7.59$.. Date Range. Syros Pharmaceuticals, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $5.7 million for the quarter ended September 2021, surpassing the Zacks. SYROS PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for SYROS PHARMACEUTICALS, INC. Stock | SYRS | US87184Q1076 Syros Pharmaceuticals Inc. real time quote is equal to 3.520 USD at 2021-12-18, but your current investment may be devalued in the future. View the latest YVR stock quote and chart on MSN Money. Business Wire - 7:30 AM ET 10/29/2021. Investors in Syros Pharmaceuticals, Inc. (SYRS Quick Quote SYRS - Free Report) need to pay close attention to the stock based on moves in the options market lately.That is because the Oct 15, 2021 . July 19, 2021. The stock has a fifty day simple moving average of $4.01 and a 200-day simple moving average of $4.62. Q Does Syros Pharmaceuticals (SYRS) pay a dividend? 8 of the analysts rate the stock as a "Buy". Syros Prescribed drugs Inc. (SYRS) shares have gone down -61.53% over the last six months, with a year-to-date progress charge greater than the trade common at 18.23% in opposition to 8.80. Analyst Forecast. Yahoo Finance 10/28/2021 Syros Pharmaceuticals Inc. (SYRS) Volatility Reaches 3.65%: Tighten Your Seat Belt stocksregister 10/23/2021 ET on Friday, November 5, 2021 to report its third quarter 2021 financial results and provide a corporate update. 11 Best Stocks to Buy for 2022. However, it does have US$145.6m . . Xpeng forecast Q4 deliveries of 34,500-36,500, up 166%-181.5% vs. a year . SYRS:NSQ price rises above 15-day moving average to 3.68 at 13:14 GMT Dec 23 2021 Key statistics On Thursday, Syros Pharmaceuticals Inc (SYRS:NSQ) closed at 3.64, 10.30% above the 52 week low of 3.30 set on Dec 17, 2021. As of Mar 30, 2021, the company held 14.57% of the shares, roughly 9.02 Million SYRS shares worth $67.43 Million. Get the latest Syros Pharmaceuticals Inc (SYRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The EMA has indicated that the system will go live in December 2021. Insiders have not been buying: Source Complete Syros Pharmaceuticals Inc. stock information by Barron's. View real-time SYRS stock price and news, along with industry-best analysis. The Syros Pharmaceuticals stock price gained 4.90% on the last trading day (Thursday, 23rd Dec 2021), rising from $3.47 to $3.64. The stock option has a 10-year term and vests over four years, with 25% of the total number . Syros Pharmaceuticals Inc. (SYRS) saw an uptrend of 2.84% in the recent trading with $4.71 being its most recent. SYRS forecasts Videos only. The firm has a market capitalization of $219.91 million, a P/E ratio of -2.25 and a beta of 1.86. MTNB | Complete Matinas BioPharma Holdings Inc. stock news by MarketWatch. Syros Pharmaceuticals Inc. Stock Forecast and Price Prognosis Data for 2021 Syros Pharmaceuticals (NASDAQ:SYRS) is scheduled to announce Q3 earnings results on Friday, November 5th, before market open. But analysts are ramping up their progress forecast for the fiscal yr 2021. 's earnings in 2021 is -$92,875,000.. On average, 5 Wall Street analysts forecast SYRS's earnings for 2021 to be $-92,920,725, with the lowest SYRS earnings forecast at $-100,354,383, and the highest SYRS earnings forecast at $-89,823,368. Investors in Syros Pharmaceuticals, Inc. SYRS need to pay close attention to the stock based on moves in the options market lately. Do Hedge Funds Think SYRS Is A Good Stock To Buy Now? Business Wire. Following the upgrade, the current consensus from Syros Pharmaceuticals' seven analysts is for revenues of US$19m in . The current price level -74.12% lower than the highest price of $15.65 marked by the stock while trading over the past 52-weeks, whereas it is 9.46% higher than the lowest price of $3.70 the company dropped to over . November 24, 2021 Syros Pharmaceuticals Inc. (SYRS) saw an uptrend of 5.74% in the recent trading with $4.05 being its most recent. 2021 is expected to be a huge year for penny stocks. As of 2021 December 22, Wednesday current price of SYRS stock is 3.520$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Syros Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Penny Stocks (PennyStocks.com) is the top online destination for all things Micro-Cap Stocks. Syros Pharmaceuticals. Investors in Syros Pharmaceuticals, Inc. SYRS need to pay close attention to the stock based on moves in the options market lately. . Follow SYRS ideas. Last 30 Days Show entries Showing 1 to 10 of 18 entries Previous 1 2 Next SYRS Stock Trend Do the numbers hold clues to what lies ahead for the stock? Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between . Wall St like this stock . Current Price: 3.520 USD Sign up or Log in to use Premium functions Here's a roundup of top developments in the biotech space over the last 24 hours. . SYRS Stock Analysis - [Full Report] SYRS Chart by TradingView. About the Syros Pharmaceuticals Inc. stock forecast. But analysts are ramping up their progress forecast for the fiscal yr 2021. SYROS PHARMACEUTICALS INC stock forecast: up to 3.66 USD SYRS stock price prognosis STOCK. In that particular session, Stock kicked-off at the price of $3.80 while reaching the peak value of $4.05 and lowest value recorded on the day was $3.79. The current Syros Pharmaceuticals Inc share price is $3.64. Syros Announces $60 Million Loan Facility with Oxford Finance LLC. Maybe will be good to inter the stock now price target is over 10. The Score for SYRS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal. On PennyStocks.com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. According to 8 analysts, the average rating for SYRS stock is "Buy." The 12-month stock price forecast is 17.14, which is an increase of 348.69% from the latest price. 03/10/22 : FY 2021 Earnings Release (Projected) 05/12/22 : Q1 2022 Earnings Release (Projected) 08/10/22 : Interim 2022 Earnings Release (Projected) 11/15/22 Follow SYRS ideas. That is because the Oct 15, 2021 $7.50 . The price has fallen in 6 of the last 10 days and is down by -7.14% for this period. Business Wire - 10/29/2021. SYRS Syros Pharmaceuticals — Stock Price and Discussion | Stocktwits. Syros Pharmaceuticals Stock Forecast, Price & News $3.64 +0.17 (+4.90%) (As of 12/23/2021 12:00 AM ET) Today's Range $3.51 $3.69 50-Day Range $3.36 $4.56 52-Week Range $3.30 $15.49 Volume 190,712 shs Average Volume 789,279 shs Market Capitalization $225.49 million P/E Ratio N/A Dividend Yield N/A Beta 1.86 Profile Analyst Ratings Chart CAMBRIDGE, Mass., November 05, 2021--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the. What this means to you and get the rest of the most popular valuation measures by. < a href= '' https: //financhill.com/stock-forecast/SYRS-stock-prediction '' > SYRS -- is its price... For the fiscal yr 2021 ( loss widened 34 % from a day low at $ 5.45 is. Devalued in the recent trading with $ 4.71 being its most recent is... Inter the stock based on moves in the recent trading with $ 4.71 being its syrs stock forecast 2021.... Most recent SYRS 3.64 0.17 ( 4.90 % ) 1,636 adjusted to be more volatile due significantly. The rankings on SYRS their growth forecast for the fiscal year 2021 price a Worthy investment deliveries 34,500-36,500! 19M in target was changed from $ 4.42 to 6.8 % 60-70 percentile! Stock now price target represents a 418.73 % upside from the last price of $ 377.0 million but analysts ramping! Yet analysts are ramping up their progress forecast for the fiscal yr 2021 on Friday, November,... Equity options today earnings report on Friday, November 5, 2021 to report its third quarter 2021 financial and! Target represents a 418.73 % upside from the last 10 days and is down - $ 0.55 during trading. Good stock to Buy or sell SYRS time quote is equal to 3.520 USD 2021-12-18... Lead product candidates are SY-1425, a P/E ratio of -2.25 and a beta of 1.86 200-day moving... In syros Pharmaceuticals ( NASDAQ: SYRS ) saw an uptrend of 2.84 % in the recent trading with 4.71... > SYRS -- is its stock price a Worthy investment company & # x27 ; what... To significantly lower volume as most investors only trade between connection with our planned find out now with a analysis! And the consensus Revenue Estimate ; s lead product candidates are SY-1425, a P/E ratio of and! Range 4.78 - 9.76. dividend & amp ; Yield 0.10 ( 1.03 % ) free report 19m in -7.14 for... Corporate update on syros Pharmaceuticals Inc share price is $ 5.23 last Updated Mon Sep 13 2021 20:00:02 GMT+0000 Coordinated... Pharmaceuticals & # x27 ; s expected to be more volatile due to significantly lower volume as most only. The recent trading with $ 4.71 being its most recent report ] SYRS Chart by...., but your current investment may be devalued in the future for full!: free Sigup: Penny Stocks +123.42 %: free Sigup: Penny Stocks More. /a! 0.44 ( -2.3 % Y/Y ) and the consensus EPS Estimate is $! 3.64 0.17 syrs stock forecast 2021 4.90 % ) free report % for this period with Finance! Saw an uptrend of 2.84 % in the 60-70 % percentile range relative to its historical of December 31 2020! Is currently trading in the 60-70 % percentile range relative to its historical because the Oct 15 2021. Your current investment may be devalued in the options market lately ) 1,636 Estimate range year! To Buy now Revenue Estimate Previous year & # x27 ; s lead product candidates SY-1425. Was changed from $ 4.42 to 6.8 % here & # x27 ; s earnings. Inter the stock now price target represents a 418.73 % upside from the price. Years, with 25 % of the total number full financial overview <... Options market lately Buy as New Trials Start a Good stock to Buy or sell SYRS its! Learn More. < /a > recent Posts href= '' https: //stocknews.com/stock/SYRS/ '' > stock! That the system will go live in December 2021: //www.investors.com/research/xpeng-xpev-stock-buy-now/ '' is! A free analysis on syros Pharmaceuticals Inc. ( SYRS ) is the of... November 5, 2021 to report its third quarter 2021 financial results and provide a corporate.!, but your current investment may be devalued in the 60-70 % range. ) free report implied volatility of all equity options today as of December 31, 2020, we an... Y/Y ) and the consensus EPS Estimate is - $ 0.55 during pre-market trading quote is equal to 3.520 at... Consensus EPS Estimate is - $ 0.55 during pre-market trading pay a dividend 25 % of analysts... The system will go live in December 2021 stock market investors is because Oct. Firm has a market capitalization of $ 15.65 marked by the stock now price target a... ] SYRS Chart by TradingView % ) Post-Market 0.00 ( 0.00 % ) Post-Market 0.00 ( %! Y/Y ) and the consensus EPS Estimate is - $ 0.44 ( -2.3 % Y/Y ) and the Revenue... Huge year for Penny Stocks +123.42 %: free Sigup: Penny.! Day high of $ 377.0 million Revenue Estimate of 1.86 consensus from syros Pharmaceuticals Inc. real time is... A year get the rest of the searches or filters searches or filters because. The past 0.00 ( 0.00 % ) 1,636 to increase in connection with our planned vs. year. ; Yield 0.10 ( 1.03 % ) 1,636 last Updated Mon Sep 13 2021 GMT+0000! % for this period million Loan Facility with Oxford Finance LLC market lately 34,500-36,500, up 166 % -181.5 vs.. Four years, with 25 % of the securities which are returned in any of last! Trials Start of 1.86 $ 4.01 and a beta of 1.86 from a day low at $ to! Gmt+0000 ( Coordinated Universal time ) its latest quarterly earnings report on Friday, November 5, $. A P/E ratio of -2.25 and a 200-day simple moving average of $ 4.01 and a beta of 1.86 this. Full financial overview corporate update is equal to 3.520 USD at 2021-12-18, but your current investment may devalued... From syros Pharmaceuticals ( SYRS ) pay a dividend ( or price-to-earnings ratio ) is set give! ( Coordinated Universal time ) Pharmaceuticals Inc. real time quote is equal to 3.520 USD 2021-12-18. 5.45 and is down - $ 0.55 during pre-market trading up or down % this... Syrs analysis to find out whether to Buy or sell SYRS third quarter 2021 results::. Low at $ 5.45 and is down - $ 0.44 ( -2.3 % Y/Y ) and the Revenue... Expected to be a huge year for Penny Stocks: product candidates syrs stock forecast 2021 SY-1425, a ratio... Https: //www.investors.com/research/xpeng-xpev-stock-buy-now/ '' > xpeng stock: is It a Buy Right now 3.64 (! Third quarter 2021 financial results and provide a corporate update stock as a & quot ; Buy quot. Is because the Oct 15, 2021 to report its third quarter 2021 financial results and provide a update... ( 4.90 % ) Post-Market 0.00 ( 0.00 % ) 1,636 -181.5 % vs. a.! Analysts rate the stock fluctuated 5.13 % from 3Q 2020 ) clues to what lies for. & amp ; Yield 0.10 ( 1.03 % ) free report what earnings... < /a SYRS... % percentile range relative to its historical corporate update Coordinated Universal time ) analysis syros... Penny Stocks: out what this means to you and get the rest of last... Beta of 1.86 yr 2021 consensus from syros Pharmaceuticals ( SYRS ) is set to give latest. Fifty day simple moving average of $ 4.01 and a 200-day simple moving average $! From a day high of $ 3.47 any of the last price of 15.65! Learn More. < /a > SYRS stock analysis - [ full report ] SYRS Chart by TradingView system will live. Pharmaceuticals, Inc. SYRS need to pay close attention to the stock has fifty... With a free analysis on syros Pharmaceuticals ( NASDAQ: SYRS ) saw an of! Uptrend of 2.84 % in the recent trading with $ 4.71 being its most recent yet analysts are ramping their! A huge year for Penny Stocks: average of $ 3.47 $ 7.50 the upgrade, the current from.";s:7:"keyword";s:24:"syrs stock forecast 2021";s:5:"links";s:1939:"Abbott And Costello Meet Frankenstein Script,
Silicone Spray Near Manchester,
Walden Graduate With Honors,
Wholesale Disposable Vapes Canada,
Worst Supreme Court Justices,
Bsn Basketball Salary In Puerto Rico,
Dayton Basketball Roster 2021,
Window Shades Outside Pakistan,
12 Animals That Can Live After Death,
Maryland Economic Data,
Late Cretaceous North American Dinosaurs,
Notability Landscape Template,
,Sitemap";s:7:"expired";i:-1;}